These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 2232146)

  • 21. Simultaneous multiresidue determination of metronidazole and spiramycin in fish muscle using high performance liquid chromatography with UV detection.
    Maher HM; Youssef RM; Khalil RH; El-Bahr SM
    J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Dec; 876(2):175-81. PubMed ID: 19013111
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Quantitative analyses of spiramycin and acetylspiramycin by thin-layer chromatography].
    Sun C; Yu RG; Yang QH; Sheng SG; Zhao XF
    Yao Xue Xue Bao; 1987 Jul; 22(7):515-9. PubMed ID: 3450151
    [No Abstract]   [Full Text] [Related]  

  • 23. Separation of spiramycin components using high-speed counter-current chromatography.
    Oka H; Harada K; Suzuki M; Ito Y
    J Chromatogr A; 2000 Dec; 903(1-2):93-8. PubMed ID: 11153959
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Experience in treatment of Mycoplasma pneumoniae with acetylspiramycin].
    Ito A; Murohashi K; Matsumura M; Honda A; Maruta I; Obara K
    Jpn J Antibiot; 1983 Apr; 36(4):699-708. PubMed ID: 6410100
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Studies on the activity of Obioactin with acetylspiramycin on mice infected with Toxoplasma gondii.
    Suzuki N; Espinas FM; Sakurai H; Saito A; Sasaki H; Kato G; Manba K; Taniguchi K; Mochizuki K; Osaki H
    Zentralbl Bakteriol Mikrobiol Hyg A; 1984 Mar; 256(3):367-80. PubMed ID: 6730783
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of impurities in spiramycin by liquid chromatography/ion trap mass spectrometry.
    Pendela M; Govaerts C; Diana J; Hoogmartens J; Van Schepdael A; Adams E
    Rapid Commun Mass Spectrom; 2007; 21(4):599-613. PubMed ID: 17262895
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis of a mixed-model stationary phase derived from glutamine for HPLC separation of structurally different biologically active compounds: HILIC and reversed-phase applications.
    Aral T; Aral H; Ziyadanoğulları B; Ziyadanoğulları R
    Talanta; 2015 Jan; 131():64-73. PubMed ID: 25281074
    [TBL] [Abstract][Full Text] [Related]  

  • 28. S-naproxen-beta-1-O-acyl glucuronide degradation kinetic studies by stopped-flow high-performance liquid chromatography-1H NMR and high-performance liquid chromatography-UV.
    Mortensen RW; Corcoran O; Cornett C; Sidelmann UG; Lindon JC; Nicholson JK; Hansen SH
    Drug Metab Dispos; 2001 Apr; 29(4 Pt 1):375-80. PubMed ID: 11259319
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Effectiveness of acetylspiramycin for Mycoplasma pneumonia in children (author's transl)].
    Iguchi K; Ninomiya T; Kamiya H; Yoshizumi T; Ukyo M; Kobayashi K; Nishi H; Iwasa T
    Jpn J Antibiot; 1981 Jul; 34(7):1071-7. PubMed ID: 7321185
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of the components of bitespiramycin by liquid chromatography-mass spectrometry.
    Wang MJ; Xue J; Zou WB; Wang Y; Hu CQ; Hoogmartens J; Adams E
    J Pharm Biomed Anal; 2012 Jul; 66():402-10. PubMed ID: 22482901
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Two novel spiramycins obtained from commercial samples: isolation and elucidation of structure.
    Liu L; Roets E; Busson R; Vankeerberghen A; Janssen G; Hoogmartens J
    J Antibiot (Tokyo); 1996 Apr; 49(4):398-401. PubMed ID: 8642006
    [No Abstract]   [Full Text] [Related]  

  • 32. Determination of spiramycin and neospiramycin antibiotic residues in raw milk using LC/ESI-MS/MS and solid-phase extraction.
    Wang J; Leung D
    J Sep Sci; 2009 Feb; 32(4):681-8. PubMed ID: 19165836
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Clinical use of acetylspiramycin for primary atypical pneumonia in the field of pediatrics].
    Maruno H; Miyazawa W; Tahara K; Miyazaki M; Kinoshita T; Shinozuka T
    Jpn J Antibiot; 1982 Aug; 35(8):2131-6. PubMed ID: 7154255
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chemical modification of spiramycins. IV. Synthesis and in vitro and in vivo activities of 3'',4''-diacylates and 3,3'',4''-triacylates of spriamycin I.
    Sano H; Sunazuka T; Tanaka H; Yamashita K; Okachi R; Omura S
    J Antibiot (Tokyo); 1984 Jul; 37(7):760-72. PubMed ID: 6469870
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chemical modification of spiramycins. III. Synthesis and antibacterial activities of 4''-sulfonates and 4''-alkylethers of spiramycin I.
    Sano H; Sunazuka T; Tanaka H; Yamashita K; Okachi R; Omura S
    J Antibiot (Tokyo); 1984 Jul; 37(7):750-9. PubMed ID: 6469869
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Stability indicating high performance liquid chromatography methods for 5-fluorouridine in aqueous solution.
    Dorta MJ; Munguía O; Fariña JB; Martin VS; Llabrés M
    Arzneimittelforschung; 1997 Dec; 47(12):1388-92. PubMed ID: 9450169
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comprehensive separation and identification of chemical constituents from Apocynum venetum leaves by high-performance counter-current chromatography and high performance liquid chromatography coupled with mass spectrometry.
    Zhang Y; Liu C; Zhang Z; Wang J; Wu G; Li S
    J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Nov; 878(30):3149-55. PubMed ID: 20965796
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comprehensive high temperature two-dimensional liquid chromatography combined with high temperature gradient chromatography-infrared spectroscopy for the analysis of impact polypropylene copolymers.
    Cheruthazhekatt S; Harding GW; Pasch H
    J Chromatogr A; 2013 Apr; 1286():69-82. PubMed ID: 23489491
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Investigations on the high molecular weight foaming fractions of espresso coffee.
    D'Agostina A; Boschin G; Bacchini F; Arnoldi A
    J Agric Food Chem; 2004 Nov; 52(23):7118-25. PubMed ID: 15537326
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Forced degradation and impurity profiling: recent trends in analytical perspectives.
    Jain D; Basniwal PK
    J Pharm Biomed Anal; 2013 Dec; 86():11-35. PubMed ID: 23969330
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.